Latest Merck Analyte Update Now Available!
Your latest comprehensive guide to multiplex and Single Protein Detection assays is now available!
20Mar
News
13Feb
Buy 2 MILLIPLEX Kits and Get the 3rd FREE
For the month of February only, buy 2 MILLIPLEX Kits and receive the 3rd FREE.
06Nov
New Product – MILLIPLEX Bovine Cytokine/Chemokine Panel 1
Inflammation plays a central role in the aetiology of many immunologically related diseases, such as infectious disease, osteoarthritis and respiratory disease, as well as neurologic, metabolic and cardiovascular disease and cancer.
10Jul
Bring Your Biomarkers to Life
As your research uncovers the significant role of biomarkers in normal and disease states, you need a reliable partner for quality assays and consistent performance.
02Oct
NEW Merck MILLIPLEX® MAP Human Cancer Autoantibody Panel
New Merck MILLIPLEX® MAP Human Cancer Autoantibody Panel, a 15-plex customisable panel.
18Sep
Launch of the Idylla™ ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only)
Being the third¹ liquid biopsy test for Biocartis, the newly launched assay, Idylla™ ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only), also marks an important milestone in the partnership with the leading science and technology company Merck².
18Sep
Biocartis launches second liquid biopsy assay
Biocartis, an innovative molecular diagnostics company, today announces the launch of its second liquid biopsy assay, the Idylla™ ctKRAS Mutation Assay (Research Use Only, RUO), which was developed in partnership with the leading science and technology company Merck1 on Biocartis’ molecular diagnostics platform Idylla™.
29May
Introducing the SMCxPRO
Introducing the SMCxPRO – sensitivity you can count on!
19Feb
Webinar: Multiplex assays of the anti-apoptotic BCL-2 family
Multiplex assays of the anti-apoptotic BCL-2 family
A hallmark of cancer cells is defects in the apoptotic cell death program.